Invesco Biotechnology & Genome ETF
PBE
PBE
51 hedge funds and large institutions have $60.7M invested in Invesco Biotechnology & Genome ETF in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.04% more ownership
Funds ownership: 25.67% → 27.71% (+2%)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.53M | |
| 2 | +$2.33M | |
| 3 | +$1.99M | |
| 4 |
LPL Financial
San Diego,
California
|
+$947K |
| 5 |
WA
WFG Advisors
Dallas,
Texas
|
+$882K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$810K | |
| 3 | -$124K | |
| 4 |
WB
Webster Bank
Waterbury,
Connecticut
|
-$45.6K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$34.7K |